abstract |
The present invention provides methods and compositions for the treatment of disease of the eye, such as retinitis pigmentosa (RP) and glaucoma, by delivery of a transgene encoding a therapeutic polypeptide, such as glial cell-derived neurotrophic factor (GDNF), specifically to Müller glial cells using a gene delivery vector. In one embodiment, the gene delivery vector is a pseudotyped retroviral vector, particularly a lentiviral vector. |